IRIS
COLAGROSSI, LUNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.826
AS - Asia 885
EU - Europa 706
SA - Sud America 196
Continente sconosciuto - Info sul continente non disponibili 125
AF - Africa 32
OC - Oceania 4
Totale 4.774
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.759
SG - Singapore 346
IT - Italia 247
BR - Brasile 156
CN - Cina 131
RU - Federazione Russa 110
BD - Bangladesh 108
HK - Hong Kong 83
VN - Vietnam 75
DE - Germania 59
IE - Irlanda 57
KR - Corea 48
SE - Svezia 43
FI - Finlandia 41
FR - Francia 37
GB - Regno Unito 34
JP - Giappone 34
CA - Canada 33
MX - Messico 16
AR - Argentina 15
IN - India 15
NL - Olanda 15
ZA - Sudafrica 14
PL - Polonia 13
CZ - Repubblica Ceca 10
ID - Indonesia 10
TR - Turchia 10
UA - Ucraina 10
AT - Austria 8
ES - Italia 8
PY - Paraguay 7
CO - Colombia 6
AU - Australia 4
EC - Ecuador 4
KE - Kenya 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
IQ - Iraq 3
JM - Giamaica 3
PE - Perù 3
PH - Filippine 3
PK - Pakistan 3
TT - Trinidad e Tobago 3
TZ - Tanzania 3
BE - Belgio 2
CH - Svizzera 2
GR - Grecia 2
MA - Marocco 2
NG - Nigeria 2
NI - Nicaragua 2
RS - Serbia 2
SA - Arabia Saudita 2
SV - El Salvador 2
UZ - Uzbekistan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
CM - Camerun 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
KZ - Kazakistan 1
PA - Panama 1
PR - Porto Rico 1
RO - Romania 1
TD - Ciad 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.650
Salva come PNG Salva come JPEG
Città #
Wilmington 478
Houston 347
Ashburn 200
Singapore 187
San Jose 141
Woodbridge 132
Fairfield 98
Chandler 92
Council Bluffs 92
Hong Kong 81
Beijing 74
New York 69
Rome 66
Dallas 49
The Dalles 49
Los Angeles 45
Dublin 44
Santa Clara 40
Seattle 37
Tokyo 33
Cambridge 29
Munich 28
Denver 27
Milan 27
Helsinki 26
Ho Chi Minh City 26
Ann Arbor 25
Medford 24
North Bergen 19
Dearborn 18
Moscow 18
Buffalo 17
Hanoi 15
São Paulo 15
London 13
Chicago 12
Johannesburg 11
Lappeenranta 11
Lauterbourg 11
Lawrence 11
Engelhard 10
Frankfurt am Main 10
Nuremberg 10
Warsaw 10
Phoenix 9
Toronto 9
Atlanta 8
Boston 8
Menlo Park 8
Montreal 8
Orem 8
San Diego 8
Stockholm 7
Boardman 6
Creede 6
Jakarta 6
Olomouc 6
Poplar 6
Querétaro 6
Redondo Beach 6
Rio de Janeiro 6
St. George 6
Brooklyn 5
Cedarhurst 5
Chennai 5
Colorado Springs 5
Fortaleza 5
Hải Dương 5
Modena 5
Naples 5
Nepi 5
New Orleans 5
San Francisco 5
Albano Laziale 4
Bologna 4
Brasília 4
Brno 4
Manchester 4
Mexico City 4
Paris 4
Amsterdam 3
Ankara 3
Asunción 3
Biên Hòa 3
Charlotte 3
Dar es Salaam 3
Florence 3
Guangzhou 3
Guarulhos 3
Istanbul 3
Jacksonville 3
Las Vegas 3
Manaus 3
Miami 3
Minneapolis 3
Monte Vista 3
Nairobi 3
Newark 3
Nova Iguaçu 3
Palazzolo sull'Oglio 3
Totale 3.047
Salva come PNG Salva come JPEG
Nome #
Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal 467
High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance 392
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 352
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro 282
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection 276
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe 269
Pre-vaccination immune markers predict response to BNT162b2 mRNA vaccine in vulnerable groups – The CONVERS project, report from a pediatric tertiary hospital 151
Managing low-level HIV viraemia in antiretroviral therapy: a systematic review and meta-analysis 148
CMV seroprevalence and coronary CMV-DNA detection in immunocompetent patients with heart diseases 148
Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis B 138
BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed? 136
SARS-CoV-2 genomic surveillance and reliability of PCR single point mutation assay (SNPsig® SARS-CoV-2 EscapePLEX CE) for the rapid detection of variants of concern in Cameroon 130
Safety of Nirmatrelvir-Ritonavir Administration in Children With Immunodeficiency and/or Comorbidities With SARS-CoV-2 Infection A Retrospective Clinical Report 116
Humoral and cellular response following vaccination with the BNT162b2 mRNA COVID-19 vaccine in patients affected by primary immunodeficiencies 116
Case Report: Successful Treatment With Monoclonal Antibodies in One APDS Patient With Prolonged SARS-CoV-2 Infection Not Responsive to Previous Lines of Treatment 115
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 113
Management of low-level HIV viremia during antiretroviral therapy: Delphi consensus statement and appraisal of the evidence 113
Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens 112
Safety and Long-Term Immunogenicity of BNT162b2 Vaccine in Individuals with Down Syndrome 112
Parvovirus B19 Rebound 109
Presence and Significance of Multiple Respiratory Viral Infections in Children Admitted to a Tertiary Pediatric Hospital in Italy 108
Highly specific memory b cells generation after the 2nd dose of bnt162b2 vaccine compensate for the decline of serum antibodies and absence of mucosal iga 106
A new epidemic wave of Bordetella pertussis in paediatric population: impact and role of co-infections in pertussis disease 103
An increase in the levels of middle surface antigen characterizes patients developing HBV-driven liver cancer despite prolonged virological suppression 101
Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity 99
Assessing the utilization of HIV genotype resistance testing: Insight from Italian Infectious Diseases Units 87
Influenza viruses circulation in a tertiary care children hospital in Rome: a comparison between 2022 and the previous 5 years 82
Diagnostic Concordance of Two- and Three-Gene SARS-CoV-2 Molecular Assays in Cameroon: Implications for Efficient Pandemic Response in Low- and Middle-Income Countries 72
Whooping Cough Cases Increase in Central Italy after COVID-19 Pandemic 69
Humoral and cellular immunogenicity and safety up to 4 months after vaccination with BNT162B2 mRNA COVID-19 vaccine in heart and lung transplanted young adults 58
Viral dynamics and factors associated with duration of COVID-19 positivity: evidence from the first-three epidemiological waves in Cameroon 37
Viral Burden of Respiratory Syncytial Virus and Viral Coinfections as Factors Regulating Paediatric Disease Severity 32
Whole-Genome Sequencing of Adenovirus Genotypes and Clinical Implications in Pediatric Patients 25
Totale 4.774
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.923
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022138 0 0 0 4 20 3 7 1 54 11 6 32
2022/2023300 18 26 18 20 39 45 40 24 27 9 28 6
2023/2024141 10 21 12 4 19 28 13 4 2 11 1 16
2024/2025718 14 105 63 36 21 41 64 60 79 85 71 79
2025/20261.646 136 89 193 147 144 70 167 177 133 154 162 74
2026/2027559 102 75 205 177 0 0 0 0 0 0 0 0
Totale 4.774